GNRSQ (The Greenrose Holding Co) Research & Development: $0.00 Mil (TTM As of Sep. 2022)


What is The Greenrose Holding Co Research & Development?

The Greenrose Holding Co GNRSQ -99.00% Research & Development is $0.00 Mil as of Sep. 2022.

Research & Development is the aggregate amount of research and development expenses during the year. The Greenrose Holding Co's Research & Development for the three months ended in Sep. 2022 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2022 was $0.00 Mil.

The Greenrose Holding Co  (OTCPK:GNRSQ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

The Greenrose Holding Co Research & Development Related Terms

The Greenrose Holding Co Research & Development Historical Data

* Premium members only.

The historical data trend for The Greenrose Holding Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Greenrose Holding Co Research & Development Chart

The Greenrose Holding Co Annual Data
Trend Dec19 Dec20 Dec21
Research & Development
0.00 0.00 0.00

The Greenrose Holding Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

The Greenrose Holding Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
The Greenrose Holding Co (GNRSQ) has a Research & Development of $0.00 Mil as of Sep. 2022. Research and development expense is the total cost for research and development activities. View historical data on The Greenrose Holding Co and its competitors.
Is The Greenrose Holding Co's Research & Development too high?
The Greenrose Holding Co's current Research & Development is $0.00 Mil.
How does The Greenrose Holding Co's Research & Development compare to STLY and BLMS?
The Greenrose Holding Co's Research & Development of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on The Greenrose Holding Co and its competitors. The Greenrose Holding Co's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Greenrose Holding Co stock overvalued right now?
The Greenrose Holding Co (GNRSQ) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For The Greenrose Holding Co (GNRSQ), the current Research & Development is $0.00 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Greenrose Holding Co Business Description

Other Exchanges GNRUQ:USA
Address 111 Broadway, Amityville, NY, USA, 11701
The Greenrose Holding Co is engaged in the manufacture and processing of cannabis in the adult-use and medical cannabis marketplace in Connecticut and Arizona.